Pancreatic Cancer Research

ResearcherMedical College of WisconsinActive in the last 2 years

Michael B. Dwinell

Matched on ORCID iD 0000-0001-5372-633X; OpenAlex author ID A5081128645; NIH RePORTER profile ID 1873996. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 8)
Trials
0
Grants
2
Labs led
1
Collaborators
20
Papers, trials and grants by year

2014: 2 papers · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper, 1 grant · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 grant · 2024: none · 2025: none · 2026: 2 papers

Papers 12

  1. Mitochondria-targeted metformin analogs activate the ER stress-unfolded protein response pathway to drive apoptosis in pancreatic cancer. Last author DOI 10.1038/s41419-026-08859-y↗
  2. Mutant KRAS promotes NF-κB driven CCL20 chemokine expression in pancreatic ductal adenocarcinoma Last author DOI 10.64898/2026.04.13.717530↗
  3. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer. Last author DOI 10.1016/j.jcmgh.2021.01.018↗
  4. A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Meta… Co-author DOI 10.1158/1055-9965.epi-18-0813↗
  5. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. Last author DOI 10.1186/s40425-019-0573-5↗
  6. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models. Co-author DOI 10.1186/s12885-018-4238-4↗
  7. Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/labinvest.2016.146↗
  8. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells. Co-author DOI 10.1158/0008-5472.can-15-2534↗
  9. Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells. Last author DOI 10.1002/mc.22091↗
  10. Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling. Last author DOI 10.1158/0008-5472.can-14-2645↗
  11. Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. Co-author DOI 10.1038/bjc.2014.272↗
  12. CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. Last author DOI 10.1371/journal.pone.0090400↗

Grants 2

  1. Biased chemokine receptor signaling in cancer progression R01CA226279↗
  2. Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis U01CA178960↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Balaraman Kalyanaraman · 4 shared papers, 1 shared grant, 2014–2026 · strength 0.75
  2. Donovan Drouillard · 2 shared papers, 2026 · strength 0.69
  3. Susan Tsai · 6 shared papers, 2014–2019 · strength 0.37
  4. Emily P. Vonderhaar · 3 shared papers, 2017–2021 · strength 0.30
  5. Jill A. Gershan · 3 shared papers, 2018–2019 · strength 0.26
  6. Maria Poimenidou · 1 shared paper, 2026 · strength 0.26
  7. Douglas B. Evans · 4 shared papers, 2014–2018 · strength 0.23
  8. Ishan Roy · 4 shared papers, 2014–2017 · strength 0.22
  9. Noah P. Zimmerman · 4 shared papers, 2014–2017 · strength 0.22
  10. Alexander Craig Mackinnon · 3 shared papers, 2014–2019 · strength 0.20
  11. Gang Cheng · 2 shared papers, 2014–2016 · strength 0.10
  12. Weiqing Jing · 1 shared paper, 2019 · strength 0.10
  13. Mohammed Aldakkak · 1 shared paper, 2019 · strength 0.08
  14. Jian Zhang · 1 shared paper, 2019 · strength 0.08
  15. Michael A. James · 1 shared paper, 2018 · strength 0.08
  16. Rosa F. Hwang · 1 shared paper, 2017 · strength 0.06
  17. Janusz Franco‐Barraza · 1 shared paper, 2017 · strength 0.06
  18. Edna Cukierman · 1 shared paper, 2017 · strength 0.06
  19. Brian F Volkman · 1 shared paper, 2015 · strength 0.04
  20. Dannielle D. Engle · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.